Home Others Others 4-Methylumbelliferyl beta-D-glucopyranoside

research use only

4-Methylumbelliferyl beta-D-glucopyranoside

Cat.No.E4012

4-Methylumbelliferyl beta-D-glucopyranoside(MUD) is a β-D-glucoside, is a fluorogenic substrate for β-glucosidase. It is utilized in the assay of beta-glucosidase activity.
4-Methylumbelliferyl beta-D-glucopyranoside Chemical Structure

Chemical Structure

Molecular Weight: 338.31

Jump to Mechanism of Action Solubility Chemical Information, Storage & Stability

Quality Control

Batch: E401201 DMSO]68 mg/mL]false]Water]2 mg/mL]false]Ethanol]Insoluble]false Purity: 99.87%
99.87

Chemical Information, Storage & Stability

Molecular Weight 338.31 Formula

C16H18O8

 Storage (From the date of receipt)
CAS No. 18997-57-4 Download SDF Storage of Stock Solutions

Solubility

In vitro
Batch:

DMSO : 68 mg/mL (200.99 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : 2 mg/mL

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06286228 Not yet recruiting
Multiple Myeloma
Siriraj Hospital|Faculty of Medicine Siriraj Hospital
 April 1 2024 --
NCT06082947 Recruiting
Hematopoietic Stem Cell Transplantation|Hematologic Malignancy
Nationwide Children''s Hospital
 December 18 2023 Not Applicable
NCT05419843 Not yet recruiting
Idiopathic Aplastic Anemia|Severe Aplastic Anemia|Moderate Aplastic Anemia Requiring Transfusions
Assistance Publique - Hôpitaux de Paris
 June 2022 Phase 2
NCT03904134 Active not recruiting
Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Myelodysplastic Syndromes|Non-hodgkin Lymphoma|Hodgkin Lymphoma|Acquired Aplastic Anemia|Sickle Cell Disease
Center for International Blood and Marrow Transplant Research|National Heart Lung and Blood Institute (NHLBI)|National Cancer Institute (NCI)|Blood and Marrow Transplant Clinical Trials Network|National Marrow Donor Program|Medical College of Wisconsin
 June 14 2019 Not Applicable

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.